PhD Graduate Mahina Mitul Joins the Vaccine Research Center

Mahina Mitul talks about finding her path to becoming a postdoc at the National Institute of Allergy and Infectious Diseases, including the tweet that led her from Bangladesh to UC Irvine.

Improving Immunotherapy for Cancer Patients: Protecting the Brain

UC Irvine researchers study a potential new strategy for preserving the life-saving benefits of immunotherapies for cancer patients while reducing unwanted immune reactions in healthy tissues in the brain.

Researchers Explore the Genetics of Diabetes and Obesity with $7.8 Million NIH Award

What makes people genetically prone to diabetes and obesity? That is the central question of a new $7.8 million NIH grant for a multidisciplinary study co-led by Wei Li, PhD.

UC Irvine School of Medicine's PhD Orientation 2026

UCI School of Medicine welcomes 35 incoming PhD students for the 2026-2027 academic year.

Meet the Incoming School of Medicine PhD Students – 2026

Meet the newest 39 members of the UCI School of Medicine graduate community joining the PhD in Biomedical Sciences program this fall. See about their backgrounds and research interests below.

Two scientists made huge bets on 'impossible' cancer treatments. They're finally paying off.

It's taken at least 40 years," mRNA vaccine researcher Phil Felgner, a University of California, Irvine professor who helped develop early versions of the lipid nanoparticle technology that powers the new vaccines, said. "It's taken this much time for it to mature.

What Doctors Want You to Know About the New 'Personalized' Cancer Vaccine Making Headlines

According to Philip Felgner, PhD, a DNA and mRNA-based vaccine development expert at UC Irvine, “This is the first large phase 3 study to demonstrate meaningful clinical benefit from an individualized mRNA cancer vaccine."

Math and Medicine Join Forces to Solve a Cancer Mystery

UC Irvine scientists uncover a key cause of immunotherapy failure – and a path to overcoming it.

New Model of Human Epstein-Barr Virus Infection Helps Explain How EBV Works

How does the Epstein-Barr Virus (EBV) manipulate our immune cells during initial infection? A new “human-tonsil-in-a-dish” model offers insights.

Childhood Screen Detects Mental Health Risk

An NIH-funded research team led by Dr. Tallie Z. Baram at the University of California, Irvine and Dr. Laura Glynn at Chapman University …. added five unpredictability measures to a current adversity screen. They tested whether these measures helped improve the detection of childhood mental health conditions.